VXRT News and Press, Vaxart Inc. From 06/14/21

5 Trending Biotech Stocks To Watch In The Stock Market Now You can’t deny that biotech stocks have and continue to make headlines throughout the globe over the past year. After all, this section of the stock market contains the most active stocks today, for a good rea...

Stock price plunged in February due to perceived weak antibody responses. Now the company has analogous data showing how immune responses in other areas can overcome the lack of antibody activity. Vaxart's tablet candidates would likely be preferred over injectable competitors, so...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in  Vaxart  (NASDAQ: VXRT ) and VXRT stock are seeing gains of more than 20% at the time of writing. Shares of this clinical-stage biotech stock focused on developing oral vaccines have...

Gainers: Novan (NOVN) +74%.Urban One (UONE) +39%.Iconix Brand (ICON) +28%.Aptinyx (APTX) +24%.Carver Bancorp (CARV) +22%.Vaxart (VXRT) +21%.Xinyuan Real Estate (XIN) +20%Broadway Financial (BYFC) +18%.Amesite (AMST) +18%.Siebert Financial (SIEB) +16%.Losers: Recon Technolo...

champc/iStock via Getty Images Shares of Vaxart (VXRT) are up more than 25% to $8.97 in afternoon trading, with no news or catalysts, an indication the stock may be in the midst of a short squeeze. Two analysts cover the stock. One has a price target of $13 and the other, $18. Vaxar...

Penny Stocks That Turned Heads Over The Last 52 Weeks When it comes to finding penny stocks to buy , everyone has the same goal. Naturally, that goal is to make money and repeat the process. But with so many 1 and 2-day breakouts captivating the attention of retail traders, itȁ...

Gainers: Novan (NOVN) +81%, Aptinyx (APTX) +25%, Vaxart (VXRT) +39%, Progenity (PROG) +28%, Chemomab Therapeutics (CMMB) +9%.Losers: Orphazyme (ORPH) -41%, Curis (CRIS) -32%, Aptose Biosciences (APTO) -30%, Galecto (GLTO) -22%,&...

The prospective coronavirus vaccine maker Vaxart (NASDAQ: VXRT) crashed by 38.6% in May, according to data provided by S&P Global Market Intelligence . The tumble was caused by the company's publication of new data about its coronavirus vaccine pill on May 3, which failed ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips As you might be able to surmise from the company’s name, clinical-stage biotechnology company Vaxart  (NASDAQ: VXRT ) specializes in developing vaccines. And in the age of the Covid-19 pandemic, traders hav...

Pfizer and Moderna have already brought coronavirus vaccines to market. But that doesn't mean the window of opportunity is closed to others whose vaccine candidates are still in development. In this Motley Fool Live video recorded on May 28 , healthcare and cannabis bureau e...